Positive coverage spurs GPs to welcome Bonviva’s arrival
Roche and GlaxoSmithKline’s recently launched osteoporosis treatment Bonviva appears to have found early favour with GPs, according to PRWeek’s latest Brand Watch chart.
Sign in to continue
Need to activate your subscription?
Domain/Group Subscriptions
Click here >>
Individual Subscriptions
Click here >>
Need to activate your Subscription
Company Wide Subscriptions
Click here >>
UK Individual Subscribers
Click here >>